Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in patients with taxane-resistant metastatic breast cancer

1. Thomas, E.
2. Tabernero, J.
3. Fornier, M.
4. Conté, P.
5. Fumoleau, P.
6. Lluch, A.
7. Vahdat, L.T.
8. Bunnell, C.A.
9. Burris, H.A.
10. Viens, P.
11. Baselga, J.
12. Rivera, E.
13. Guarneri, V.
14. Poulart, V.
15. Klimovsky, J.
16. Lebwohl, D.
17. Martin, M.